Topped up in the low 50s for a long term hold.
$8 billion market and no serious competition.
This may dip further in the short term but strong news expected in Q3 and Q4.
Ann: First Patient Treatment in the U.S. in the VISABL-AFL Trial, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.54 |
Change
-0.040(2.53%) |
Mkt cap ! $491.8M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.58 | $1.51 | $534.4K | 348.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1397 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.54 | 800 | 3 |
View Market Depth
| Last trade - 14.00pm 17/06/2025 (20 minute delay) ? |
| IMR (ASX) Chart |